Government

Europe's Evolving Stance on Cannabis: Recent Developments in the Netherlands, Italy, and the UK

Published March 8, 2024

Over the past few years, Europe has witnessed a significant shift in its attitude towards cannabis, with many countries adopting more lenient policies regarding both medical and recreational use. In this landscape of change, several recent developments have emerged from the Netherlands, Italy, and the UK, spotlighting the evolution of cannabis legislation and the response from government bodies and markets.

Amsterdam Excluded from the Netherlands' Legal Cannabis Experiment

Contrary to expectations, Amsterdam, a city renowned for its liberal approach to cannabis, has not been selected to participate in the Dutch government's controlled cannabis supply experiment. This pilot program, designed to regulate the production and distribution of recreational marijuana, will precede the Netherlands without the inclusion of its most famous city. The exclusion came after a parliamentary vote dismissed a proposal that sought to bring an earlier conclusion to the longstanding tolerance policies, known locally as the 'gedoogbeleid'.

Italian Cannabis Referendum and Legislative Proposals

In Italy, the waves of reform continue to make headway with the proposed cannabis referendum gaining traction. However, despite the initial momentum, the referendum's advocates faced a setback when Italy's Constitutional Court ruled it inadmissible. Despite this, legislative efforts persist with lawmakers pushing for decriminalization and regulation of cannabis, aiming for a breakthrough in the Italian Parliament.

The UK's Medical Cannabis Prescriptions

In the United Kingdom, medical cannabis prescriptions, which were once rare and difficult to obtain, are starting to become more accessible. The gradual liberalization of policies is allowing patients with specific conditions to access medical marijuana under the NHS or through private prescriptions. It signals a modest yet meaningful shift in the UK's stance towards cannabis access for therapeutic purposes.

These highlight the dynamic and nuanced approach Europe is taking towards cannabis regulation. In the context of these developments, market participants are closely monitoring companies like Curaleaf Holdings CURLF, among others, to gauge the potential business and investment opportunities that might arise from the evolving legal landscape.

Europe, Cannabis, Legislation